Home > Healthcare > Biotechnology > Biopharma > Organoids and Spheroids Market

Organoids and Spheroids Market Trends

  • Report ID: GMI9142
  • Published Date: Apr 2024
  • Report Format: PDF

Organoids and Spheroids Market Trends

  • Technological advancements in 3D spheroid culture are instrumental in propelling the growth of the market. Cutting-edge techniques such as microfluidics and bioprinting enable precise control over the spatial organization of cells within spheroids, resulting in more complex and physiologically relevant structures.
     
  • In addition, advanced imaging technologies allow high-resolution visualization and analysis of spheroid morphology and dynamics, facilitating high-content screening for drug discovery and toxicity testing.
     
  • Moreover, integration of multi-omics approaches with 3D spheroid cultures provides comprehensive insights into cellular phenotypes and drug responses. For instance, in June 2021 Corning Incorporated announced the launch of HepGo Assay-ready 3D liver spheroid kit, the first plug-and-play solution to include 96 pre-plated primary human hepatocyte (PHH) spheroids in a single-spheroid microplate (one uniform spheroid per well) and HepGo Hepatocyte companion cell culture media. The kit provides a convenient way for customers to use 3D PHH liver spheroids for various applications, including hepatotoxicity assays. This streamlines the process by minimizing manual steps and reducing potential errors, that boosts the growth of the market.
Authors: Mariam Faizullabhoy, Gauri Wani

Frequently Asked Questions (FAQ) :

Organoids and spheroids market size was USD 1.1 billion in 2023 and is expected to register 19.1% CAGR from 2024-2032 owing to the increase in demand for personalized medicines, and a rise in investments toward R&D activities worldwide.

The organoids segment reached USD 796.9 million in 2023 and is expected to register an appreciable CAGR from 2024-2032 due to rising adoption of organoids in various applications such as disease modeling, pathogenesis, drug screening, etc.

The North America organoids and spheroids industry held 42.7% share in 2023 and is expected to register a commendable CAGR from 2024-2032 due to rising technological advancements and research and development in the region.

STEMCELL Technologies Inc., Corning Incorporated, Merck KGaA, Greiner Bio-One, InSphero Inc., Promega Corporation, Thermo Fisher Scientific Inc., Lonza Group Ltd., Prellis Biologics, and AMSBIO LLC, are some of the major organoids and spheroids companies worldwide.

Organoids and Spheroids Market Scope

Buy Now


Premium Report Details

  • Base Year: 2023
  • Companies covered: 10
  • Tables & Figures: 296
  • Countries covered: 22
  • Pages: 180
 Download Free Sample